Complement-mediated regulation of the interleukin 17A axis is a central genetic determinant of the severity of experimental allergic asthma

[1]  J. Kolls,et al.  Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. , 2009, American journal of respiratory and critical care medicine.

[2]  A. Pernis,et al.  Th17 cells in rheumatoid arthritis and systemic lupus erythematosus , 2009, Journal of internal medicine.

[3]  C. Wijmenga,et al.  The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases , 2009, Annals of the rheumatic diseases.

[4]  Martin L. Moore,et al.  A Functional IL-13 Receptor Is Expressed on Polarized Murine CD4+ Th17 Cells and IL-13 Signaling Attenuates Th17 Cytokine Production1 , 2009, The Journal of Immunology.

[5]  C. Lemière,et al.  T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. , 2009, The Journal of allergy and clinical immunology.

[6]  Jennifer R. Clark,et al.  A Protective Role for C5a in the Development of Allergic Asthma Associated with Altered Levels of B7-H1 and B7-DC on Plasmacytoid Dendritic Cells 1 , 2009, The Journal of Immunology.

[7]  H. Hammad,et al.  House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells , 2009, Nature Medicine.

[8]  H. Hartung,et al.  Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis. , 2009, International MS journal.

[9]  A. Shapiro,et al.  Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice , 2009, Diabetes.

[10]  Jennifer R. Clark,et al.  Allergen Uptake, Activation, and IL-23 Production by Pulmonary Myeloid DCs Drives Airway Hyperresponsiveness in Asthma-Susceptible Mice , 2008, PloS one.

[11]  R. Hegde,et al.  Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein , 2008, Nature.

[12]  M. Hatano,et al.  IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. , 2008, American journal of respiratory and critical care medicine.

[13]  K. Stuhlmeier,et al.  The TSC-mTOR signaling pathway regulates the innate inflammatory response. , 2008, Immunity.

[14]  A. Mandelin,et al.  TH-17 cells in rheumatoid arthritis , 2008, Arthritis research & therapy.

[15]  R. Wu,et al.  Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. , 2008, The Journal of allergy and clinical immunology.

[16]  S. Goya,et al.  Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17 , 2008, The Journal of experimental medicine.

[17]  C. Lemière,et al.  Differences in airway cytokine profile in severe asthma compared to moderate asthma. , 2008, Chest.

[18]  A. J. Valente,et al.  IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation , 2007 .

[19]  R. Geha,et al.  Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge , 2007, Proceedings of the National Academy of Sciences.

[20]  Peter O. Krutzik,et al.  Single‐Cell Phospho‐Protein Analysis by Flow Cytometry , 2007, Current protocols in immunology.

[21]  B. Ryffel,et al.  Interleukin-17 is a negative regulator of established allergic asthma , 2006, The Journal of experimental medicine.

[22]  John D Lambris,et al.  A protective role for the fifth complement component (c5) in allergic airway disease. , 2006, American journal of respiratory and critical care medicine.

[23]  John D Lambris,et al.  A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. , 2006, The Journal of clinical investigation.

[24]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[25]  Y. Belkaid,et al.  C5a negatively regulates toll-like receptor 4-induced immune responses. , 2005, Immunity.

[26]  M. Shimizu,et al.  Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma , 2004, Human Genetics.

[27]  Jonathan M Irish,et al.  Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. , 2004, Clinical immunology.

[28]  V. Imbert,et al.  AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells , 2003, Oncogene.

[29]  K. Chida,et al.  Elevated complement C3a in plasma from patients with severe acute asthma. , 2003, The Journal of allergy and clinical immunology.

[30]  W. Pierzchała,et al.  Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. , 2003, Respiratory medicine.

[31]  L. Boulet,et al.  Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. , 2003, The Journal of allergy and clinical immunology.

[32]  M. Wills-Karp,et al.  Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. , 2002, American journal of respiratory cell and molecular biology.

[33]  S. J. Hoffman,et al.  A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease , 2002, The Journal of experimental medicine.

[34]  J. Lötvall,et al.  IL‐17‐induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen‐activated protein (MAP) kinases , 2001, British journal of pharmacology.

[35]  R. Ames,et al.  Cutting Edge: Guinea Pigs with a Natural C3a-Receptor Defect Exhibit Decreased Bronchoconstriction in Allergic Airway Disease: Evidence for an Involvement of the C3a Anaphylatoxin in the Pathogenesis of Asthma1 , 2000, The Journal of Immunology.

[36]  G. Peltz,et al.  Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma , 2000, Nature Immunology.

[37]  Bao Lu,et al.  A role for the C3a anaphylatoxin receptor in the effector phase of asthma , 2000, Nature.

[38]  O. Nadiv,et al.  IL‐17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts , 2000, Clinical and experimental immunology.

[39]  M. Matthay,et al.  Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. , 2000, American journal of respiratory and critical care medicine.

[40]  B. Kelsall,et al.  Selective Suppression of IL-12 Production by Chemoattractants , 2000, The Journal of Immunology.

[41]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[42]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[43]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[44]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[45]  D. Haviland,et al.  Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon. , 1990, The Journal of biological chemistry.

[46]  D. House,et al.  Ozone-induced inflammation in the lower airways of human subjects. , 1989, The American review of respiratory disease.

[47]  A. Shapiro,et al.  Inhibition of Th 17 cells regulates autoimmune diabetes in NOD mice Running Title : A role for Th 17 cells in autoimmune diabetes , 2009 .

[48]  A. J. Valente,et al.  IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. , 2007, American journal of physiology. Heart and circulatory physiology.

[49]  耕一 長谷川.  Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma , 2007 .

[50]  A. F. Scott,et al.  Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families , 2006, Genes and Immunity.

[51]  P. Hellings,et al.  Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. , 2003, American journal of respiratory cell and molecular biology.